CURRENT LOCATION:
HOME》Technology transfer》Chemical technology transfer》Generic transfer》Epalrestat
Epalrestat

     

    Project NameEpalrestat

    Registration Classification:6+6

    Formulations and specifications Tablets: 50mg, capsules: 50mg

    IndicationsFor the prevention and treatment of diabetic complications such as the peripheral nerve disorder ( numbness , pain ) , cardiac abnormalities and abnormal vibration perception ( glycosylated hemoglobin values ??show high ) .

    Progress Pharmaceutical Research in progress

     

Links:

地址:北京市丰台区造甲街南里5号4A楼2层
电话:010-63716441 63717341 传真:010-63728443
COPYRIGHT (C) 2014 Beijing Mega Pharmaceutical Science and Technology Co.,ltd. ALL RIGHTS RESERVED
版权所有 北京满格医药科技有限公司 京ICP备12000952号